Statement by Dr. Eugen Hug, Chief Medical Officer of ProCureTreatment Centers, Regarding the University of North Carolina Study Comparing Proton Therapy and Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer
4/17/2012 10:03:41 AM
BLOOMINGTON, Ind.--(BUSINESS WIRE)--The following is a statement by Dr. Eugen Hug: A controversial conclusion reached in the study “Comparative effectiveness of intensity modulated radiation therapy, proton therapy and conformal radiation therapy in the treatment of localized prostate cancer” is firmly contradicted by a number of well-regarded peer-reviewed studies that found protons reduce – not increase – gastrointestinal side effects. The UNC study runs counter to what we know from these studies, from research being carried out by ProCure and other proton centers and from our first-hand experience treating hundreds of patients with this important cancer therapy.
comments powered by